Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. COIN
4. PINS
5. RDDT
6. FSLR
7. SYK
8. DASH
9. SBUX
10. SNDK

Go back to Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results

Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.91

November 12, 2018 4:15 PM EST

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.91).

We continue to execute on our strategy to rapidly develop CYC065 and CYC140 in hematological malignancies and CYC065 in advanced solid tumors, said Spiro Rombotis, President and Chief Executive Officer of Cyclacel. The Phase 1 study evaluating... More